FORT COLLINS, Colo., May 31, 2017 -- Advanced Energy Industries, Inc. (Nasdaq:AEIS), the global leader in precision power conversion, announced today that Yuval Wasserman, President & CEO, and Tom Liguori, EVP and CFO, will be presenting at the Citi Small and Mid Cap Conference on Thursday June 8, 2017 at 11:00 am ET at the Plaza Hotel, New York, NY.
About Advanced Energy
Advanced Energy (Nasdaq:AEIS) is a global leader in innovative power and control technologies for high-growth, precision power solutions for thin films processes and industrial applications. Advanced Energy is headquartered in Fort Collins, Colorado, with dedicated support and service locations around the world. For more information, go to www.advanced-energy.com.
CONTACTS: Tom Liguori Advanced Energy Industries, Inc. 970.407.6570 [email protected] Annie Leschin Advanced Energy Industries, Inc. 970.407.6555 [email protected]


Saks Global to End Saks on Amazon Partnership Amid Bankruptcy Restructuring
NRW Holdings Shares Surge After Securing Major Rio Tinto Contract and New Project Wins
Google Cloud and Liberty Global Forge Strategic AI Partnership to Transform European Telecom Services
Sam Altman Reaffirms OpenAI’s Long-Term Commitment to NVIDIA Amid Chip Report
Bob Iger Plans Early Exit as Disney Board Prepares CEO Succession Vote
Panama Supreme Court Voids Hong Kong Firm’s Panama Canal Port Contracts Over Constitutional Violations
SpaceX Updates Starlink Privacy Policy to Allow AI Training as xAI Merger Talks and IPO Loom
Panama Supreme Court Voids CK Hutchison Port Concessions, Raising Geopolitical and Trade Concerns
Elon Musk’s Empire: SpaceX, Tesla, and xAI Merger Talks Spark Investor Debate
Oracle Plans $45–$50 Billion Funding Push in 2026 to Expand Cloud and AI Infrastructure
Disney Board Nears CEO Decision as Josh D’Amaro Emerges as Leading Candidate
Nvidia’s $100 Billion OpenAI Investment Faces Internal Doubts, Report Says
SpaceX Reports $8 Billion Profit as IPO Plans and Starlink Growth Fuel Valuation Buzz
Denso Cuts Profit Forecast Amid U.S. Tariffs and Rising Costs
CSPC Pharma and AstraZeneca Forge Multibillion-Dollar Partnership to Develop Long-Acting Peptide Drugs 



